Factors influencing the performance level of Candida mannan antigen testing in allogeneic stem cell transplant recipients not receiving fluconazole prophylaxis

Transplant Infectious Disease

Volumn 13, Issue 3, 2011, Pages 266-272

  Nihtinen, Anne ^a   Anttila, V J ^a   Richardson, M ^b   Ruutu, T ^a   Juvonen, E ^a   Meri, T ^c   Volin, L ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Candida; Colonization; Mannan; Stem cell transplantation

Indexed keywords

ACICLOVIR; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN A; FLUCONAZOLE; FOSCARNET; FUNGUS ANTIGEN; GANCICLOVIR; MANNAN; METHOTREXATE; METHYLPREDNISOLONE; MICONAZOLE; THYMOCYTE ANTIBODY; TOBRAMYCIN; VALACICLOVIR;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA MANNAN ANTIGEN TEST; CHRONIC GRAFT VERSUS HOST DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DRUG USE; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; FECES ANALYSIS; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; GRAFT RECIPIENT; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MALE; MOUTH INFECTION; MYCOSIS; NONHUMAN; ORAL BIOPSY; PRIORITY JOURNAL; REFERENCE VALUE; RISK FACTOR; TREATMENT DURATION; URINALYSIS; VIRUS ENCEPHALITIS;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIGENS, FUNGAL; ANTIVIRAL AGENTS; CANDIDA; CANDIDA ALBICANS; CANDIDEMIA; CANDIDIASIS, INVASIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUCONAZOLE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MANNANS; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 79957987845     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00593.x     Document Type: Article

References (26)

1. Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 1999; 37: 1510-1517.
2. Rimek D, Redetzke K, Singh J, Heinrich K, Kappe R. [Performance of the Candida mannan antigen detection in patients with fungemia] {article is in German}. Mycoses 2004; 47 (Suppl 1): 23-26.
3. Allan EK, Jordanides NE, McLintock LA, Copland M, Devaney M, Stewart K. Poor performance of galactomannan and mannan sandwich enzyme-linked immunosorbent assays in the diagnosis of invasive fungal infection (letter). Br J Haematol 2004; 128: 578-579.
4. Sendid B, Poirot JL, Tabouret M, et al. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol 2002; 51: 1-10.
5. Yera H, Sendid B, Francois N, Camus D, Poulain D. Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis. Eur J Clin Microbiol Infect Dis 2001; 20: 864-870.
6. Rimek D, Redetzke K, Steiner B, Podbielski A. [Experience with the Platelia Candida ELISA for the diagnostics of invasive candidosis in neutropenic patients]. Mycoses 2004; 47 (Suppl 1): 27-31.
7. Marr KA, Seidel K, White TC, Bowden RA. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181: 309-316.
8. Zollner-Schwetz I, Auner HW, Paulitsch A, et al. Oral and intestinal Candida colonization in patients undergoing hematopoietic stem-cell transplantation. J Infect Dis 2008; 198: 150-153.
9. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845-851.
10. Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study. J Infect Dis 1995; 171: 1545-1552.
11. Jantunen E, Ruutu P, Niskanen L, et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997; 19: 801-808.
12. Jantunen E, Nihtinen A, Volin L, et al. Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis. Bone Marrow Transplant 2004; 34: 891-895.
13. Nihtinen A, Anttila V-J, Richardson M, et al. Invasive aspergillus infections in allogeneic stem cell transplant recipients: environmental sampling, nasal and oral colonization and galactomannan testing. Bone Marrow Transplant 2010; 45: 333-338.
14. Ruutu T, Volin L, Parkkali T, Juvonen E, Elonen E. Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study. Blood 2000; 96: 2391-2398.
15. Evans EGV, Richardson MD, eds. Medical Mycology: A Practical Approach. Oxford, UK: IRL Press at Oxford University Press, 1989.
16. de Pauw B, Walsh TJ, Donnelly JP, et al. European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group. National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
17. Epstein JB, Hancock PJ, Nantel S. Oral candidiasis in hematopoietic transplantation patients: an outcome-based analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 154-163.
18. Kappe R, Mueller J. Rapid clearance of Candida albicans mannan antigens by liver and spleen in contrast to prolonged circulation of Cryptococcus neoformans antigens. J Clin Microbiol 1991; 29: 1665-1669.
19. Persat F, Topenor R, Piens MA, Thiebaut A, Dannaoui E, Picot S. Evaluation of different commercial ELISA methods for the serodiagnosis of systemic candidosis. Mycoses 2002; 45: 455-460.
20. Martino P, Girmenia C, Venditti M, et al. Candida colonization and systemic infection in neutropenic patients. Cancer 1989; 64: 2030-2034.
21. Prella M, Bille J, Pugnale M, et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 2005; 51: 95-101.
22. Ellis M, Al-Ramadi B, Bernsen R, Kristensen J, Alizadeh H, Hedstrom U. Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J Med Microbiol 2009; 58: 606-615.
23. Sendid B, Caillot D, Baccouch-Humbert B, et al. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J Clin Microbiol 2003; 41: 4551-4558.
24. Arendrup MC, Bergmann OJ, Larsson L, Nielsen HV, Jarløv JO, Christensson B. Detection of candidaemia in patients with and without haematological disease. Clin Microbiol Infect 2010; 16: 855-862.
25. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69: 369-380.
26. Verduyn Lunel FM, Donnelly P, van der Lee HAL, Blijlevens NMA, Verweij PE. Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy. Clin Microbiol Infect 2009; 15: 380-386.